Carduso Capital participates in technology companies based on scientific knowledge from and/or the surroundings of the University of Groningen (UG) and the Academic Hospital of Groningen (UMCG).
Carduso Capital invests in innovative technology companies that have strong technology links with the University of Groningen (UG), the University Medical Centre Groningen (UMCG) and its affiliates. Our investments can both be categorized as early stage spin-offs and start-ups as well as established companies expanding on technology knowhow, research and skills of the institutes.
We support initiatives within the main themes of the institutes, Life Sciences/Healthy Ageing, Energy and Sustainable Society and aim for long-term cooperation’s. We envision facilitating multiple investment rounds alone or together with other co-investors and assist the entrepreneurs in realizing their plans as well as an attractive return to the investors in Carduso.
We invest in companies based in the Groningen region in the northern part of the Netherlands with products and services that meet clear and unmet easy to understand needs, based on conservative plans, scenarios and realistic assumptions. Inventions of early stage companies, start-ups and university spin-offs must have finalized a proof of concept and preferably demonstrate a workable prototype.
Carduso Capital investment strategy is formed in several stages and, depending on the proposition status, starts at a €100K investment and stretches out to a total maximum of 5.000K per initiative.
People are essential to the success of the company. Employees, initiators and management are highly qualified, top quality, professionals who have committed or are willing to commit themselves contractually for a long term to the company, also during difficult times as these adventures are never a straight way to success.